Amdocs Average Equity vs Average Assets Analysis

DOX Stock  USD 89.90  0.52  0.58%   
Trend analysis of Amdocs balance sheet accounts such as Other Current Liabilities of 1 B or Total Current Liabilities of 1 B provides information on Amdocs' total assets, liabilities, and equity, which is the actual value of Amdocs to its prevalent stockholders. By breaking down trends over time using Amdocs balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Amdocs. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.

About Amdocs Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Amdocs at a specified time, usually calculated after every quarter, six months, or one year. Amdocs Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Amdocs and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Amdocs currently owns. An asset can also be divided into two categories, current and non-current.

Amdocs Balance Sheet Chart

Amdocs Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Amdocs uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, Amdocs' Non Current Liabilities Total is fairly stable compared to the past year. Other Current Assets is likely to rise to about 307 M in 2024, whereas Total Assets are likely to drop slightly above 4.5 B in 2024.

Total Assets

Total assets refers to the total amount of Amdocs assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Amdocs books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Amdocs balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Amdocs are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.
Most indicators from Amdocs' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Amdocs current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Amdocs. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.Enterprise Value Multiple is likely to rise to 14.45 in 2024, whereas Selling General Administrative is likely to drop slightly above 390.6 M in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit1.6B1.7B2.0B1.1B
Total Revenue4.6B4.9B5.6B3.1B

Amdocs fundamental ratios Correlations

0.560.510.950.960.650.20.770.150.430.970.750.440.93-0.890.650.73-0.610.940.810.040.950.640.940.530.95
0.560.50.440.490.730.530.76-0.05-0.220.680.67-0.250.67-0.760.610.85-0.770.570.15-0.140.620.730.630.090.47
0.510.50.370.320.850.790.78-0.31-0.050.590.770.030.37-0.720.860.71-0.830.670.19-0.230.510.850.560.560.51
0.950.440.370.970.48-0.010.690.320.480.880.650.520.92-0.770.470.65-0.460.820.860.110.940.470.920.470.87
0.960.490.320.970.46-0.060.670.350.540.870.650.550.93-0.750.450.66-0.410.80.890.10.920.450.90.380.86
0.650.730.850.480.460.820.93-0.35-0.020.740.90.00.55-0.860.980.87-0.950.790.28-0.110.661.00.70.570.67
0.20.530.79-0.01-0.060.820.6-0.62-0.470.390.57-0.450.13-0.580.790.53-0.840.48-0.28-0.230.20.820.260.410.3
0.770.760.780.690.670.930.6-0.130.10.810.950.160.72-0.90.890.95-0.90.810.49-0.070.820.930.850.540.75
0.15-0.05-0.310.320.35-0.35-0.62-0.130.50.0-0.150.470.190.16-0.34-0.010.41-0.080.44-0.210.17-0.350.11-0.35-0.06
0.43-0.22-0.050.480.54-0.02-0.470.10.50.20.170.960.21-0.030.10.060.240.270.840.160.33-0.030.30.210.31
0.970.680.590.880.870.740.390.810.00.20.760.20.93-0.960.710.77-0.740.970.630.020.930.730.930.510.94
0.750.670.770.650.650.90.570.95-0.150.170.760.250.66-0.830.90.91-0.820.790.52-0.160.780.90.810.560.77
0.44-0.250.030.520.550.0-0.450.160.470.960.20.250.22-0.060.130.10.190.290.870.00.37-0.010.340.340.37
0.930.670.370.920.930.550.130.720.190.210.930.660.22-0.870.490.74-0.580.830.670.110.930.540.920.340.86
-0.89-0.76-0.72-0.77-0.75-0.86-0.58-0.90.16-0.03-0.96-0.83-0.06-0.87-0.81-0.840.89-0.94-0.480.04-0.89-0.85-0.91-0.53-0.89
0.650.610.860.470.450.980.790.89-0.340.10.710.90.130.49-0.810.8-0.890.810.34-0.170.630.980.670.640.69
0.730.850.710.650.660.870.530.95-0.010.060.770.910.10.74-0.840.8-0.830.720.44-0.080.780.860.80.40.65
-0.61-0.77-0.83-0.46-0.41-0.95-0.84-0.90.410.24-0.74-0.820.19-0.580.89-0.89-0.83-0.76-0.140.13-0.62-0.95-0.67-0.53-0.64
0.940.570.670.820.80.790.480.81-0.080.270.970.790.290.83-0.940.810.72-0.760.64-0.050.880.790.890.640.95
0.810.150.190.860.890.28-0.280.490.440.840.630.520.870.67-0.480.340.44-0.140.640.070.750.260.720.430.72
0.04-0.14-0.230.110.1-0.11-0.23-0.07-0.210.160.02-0.160.00.110.04-0.17-0.080.13-0.050.070.03-0.110.01-0.07-0.01
0.950.620.510.940.920.660.20.820.170.330.930.780.370.93-0.890.630.78-0.620.880.750.030.651.00.440.89
0.640.730.850.470.451.00.820.93-0.35-0.030.730.9-0.010.54-0.850.980.86-0.950.790.26-0.110.650.690.570.67
0.940.630.560.920.90.70.260.850.110.30.930.810.340.92-0.910.670.8-0.670.890.720.011.00.690.470.91
0.530.090.560.470.380.570.410.54-0.350.210.510.560.340.34-0.530.640.4-0.530.640.43-0.070.440.570.470.63
0.950.470.510.870.860.670.30.75-0.060.310.940.770.370.86-0.890.690.65-0.640.950.72-0.010.890.670.910.63
Click cells to compare fundamentals

Amdocs Account Relationship Matchups

Amdocs fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets6.3B6.5B6.4B6.4B7.4B4.5B
Other Current Liab794.4M886.6M821.3M849.4M976.9M1.0B
Total Current Liabilities1.2B1.3B1.3B1.4B1.6B1.0B
Total Stockholder Equity3.6B3.6B3.5B3.5B4.1B2.8B
Property Plant And Equipment Net903.4M931.9M971.2M951.9M1.1B1.1B
Net Debt50.0M172.1M253.5M287.2M258.5M271.4M
Retained Earnings5.3B5.9B6.2B6.5B7.5B7.9B
Accounts Payable930.3M121.2M134.4M293.3M337.3M428.4M
Cash983.2M709.1M573.4M520.1M598.1M720.1M
Non Current Assets Total4.3B4.4B4.4B4.5B5.2B2.6B
Non Currrent Assets Other488.6M630.7M574.9M631.6M726.3M762.6M
Cash And Short Term Investments983.9M965.6M818.0M742.5M853.9M1.0B
Net Receivables861.0M866.8M946.8M944.5M1.1B618.6M
Common Stock Shares Outstanding133.2M128.0M121.9M118.9M107.0M144.3M
Liabilities And Stockholders Equity6.3B6.5B6.4B6.4B7.4B4.5B
Non Current Liabilities Total1.5B1.6B1.6B1.5B1.7B1.8B
Other Current Assets229.6M235.1M238.4M224.6M258.3M307.0M
Other Stockholder Equity(1.7B)(2.3B)(2.6B)(3.0B)(2.7B)(2.5B)
Total Liab2.7B2.9B2.8B2.9B3.3B1.7B
Total Current Assets2.1B2.1B2.0B1.9B2.2B1.9B
Short Term Debt159.1M58.7M43.3M40.0M46.0M43.7M
Property Plant And Equipment Gross903.4M931.9M971.2M951.9M1.1B1.1B
Accumulated Other Comprehensive Income11.7M9.3M(72.5M)(53.3M)(47.9M)(45.5M)
Common Stock4.5M4.5M4.5M4.6M5.3M4.4M
Current Deferred Revenue126.8M237.4M253.7M170.6M196.2M184.3M
Other Liab542.4M586.2M750.3M793.9M913.0M469.4M
Other Assets423.9M488.6M630.7M574.9M661.2M386.6M
Good Will2.6B2.6B2.7B2.7B3.2B1.9B
Intangible Assets296.3M259.0M178.3M181.5M163.4M317.6M
Property Plant Equipment354.0M723.6M931.9M971.2M1.1B1.2B
Short Term Investments752K256.5M244.6M222.5M200.2M266.3M
Net Tangible Assets660.6M567.8M711.0M676.6M609.0M676.1M

Pair Trading with Amdocs

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amdocs position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amdocs will appreciate offsetting losses from the drop in the long position's value.

Moving against Amdocs Stock

  0.75AVPTW AvePointPairCorr
  0.66EGIO Edgio Inc Tech BoostPairCorr
The ability to find closely correlated positions to Amdocs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amdocs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amdocs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amdocs to buy it.
The correlation of Amdocs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amdocs moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amdocs moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amdocs can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Amdocs offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amdocs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amdocs Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amdocs Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Amdocs. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Complementary Tools for Amdocs Stock analysis

When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Stocks Directory
Find actively traded stocks across global markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
CEOs Directory
Screen CEOs from public companies around the world
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Is Amdocs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amdocs. If investors know Amdocs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amdocs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.18
Dividend Share
1.74
Earnings Share
4.68
Revenue Per Share
41.665
Quarterly Revenue Growth
0.05
The market value of Amdocs is measured differently than its book value, which is the value of Amdocs that is recorded on the company's balance sheet. Investors also form their own opinion of Amdocs' value that differs from its market value or its book value, called intrinsic value, which is Amdocs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amdocs' market value can be influenced by many factors that don't directly affect Amdocs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amdocs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amdocs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amdocs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.